Cart
sales@molnova.com
PD1-PD L1 inhibitor Polaris
CAS No. 2201132-36-5
PD1-PD L1 inhibitor Polaris( —— )
Catalog No. M13510 CAS No. 2201132-36-5
PD1-PD L1 inhibitor Polaris is a novel potent, small molecule inhibitor of PD-1/PD-L1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePD1-PD L1 inhibitor Polaris
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD1-PD L1 inhibitor Polaris is a novel potent, small molecule inhibitor of PD-1/PD-L1.
-
DescriptionPD1-PD L1 inhibitor Polaris is a novel potent, small molecule inhibitor of PD-1/PD-L1 interaction (IC50=0.1-10 nM in ELISA assays) with anti-cancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetPD-1/PD-L1
-
RecptorPD-1/PD-L1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2201132-36-5
-
Formula Weight834.646
-
Molecular FormulaC42H46Br2N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(2S,2'S)-1,1'-(((((2,2'-dimethyl-[1,1'-biphenyl]-3,3'-diyl)bis(methylene))bis(oxy))bis(3-bromo-4,1-phenylene))bis(methylene))bis(piperidine-2-carboxylic acid)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rotundine
Rotundine is extracted from Corydalis yanhusuo W. T. Wang.
-
Nofazinlimab
Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.
-
Pembrolizumab
Pertuzumab anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family.
